158 related articles for article (PubMed ID: 32297576)
1. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer
Kieszkowski P; Dąbruś D; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(11):1119-1128. PubMed ID: 32297576
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Changes in the Expression Profile of mRNA and Proteinencoding Adiponectin in Ishikawa Cell Line under the Influence of Cisplatin - Preliminary Report.
Kiełabsiński R; Kieszkowski P; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(12):1242-1248. PubMed ID: 32370713
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin Changes Expression of SEMA3B in Endometrial Cancer.
Peszek W; Kras P; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2020; 21(13):1368-1376. PubMed ID: 32410560
[TBL] [Abstract][Full Text] [Related]
4. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
5. Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.
Dziobek K; Opławski M; Grabarek B; Zmarzły N; Kiełbasiński R; Leśniak E; Januszyk P; Januszyk K; Adwent I; Dąbruś D; Kieszkowski P; Kiełbasiński K; Kuś-Kierach A; Boroń D
Curr Pharm Biotechnol; 2019; 20(9):727-732. PubMed ID: 31215376
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer Cells.
Dąbruś D; Kiełbasiński R; Grabarek BO; Boroń D
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531934
[TBL] [Abstract][Full Text] [Related]
7. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
[TBL] [Abstract][Full Text] [Related]
8. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.
Coma S; Amin DN; Shimizu A; Lasorella A; Iavarone A; Klagsbrun M
Cancer Res; 2010 May; 70(9):3823-32. PubMed ID: 20388805
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1.
Rao J; Zhou ZH; Yang J; Shi Y; Xu SL; Wang B; Ping YF; Chen L; Cui YH; Zhang X; Wu F; Bian XW
Cancer Lett; 2015 Mar; 358(1):76-84. PubMed ID: 25529012
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
12. ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.
Clarhaut J; Gemmill RM; Potiron VA; Ait-Si-Ali S; Imbert J; Drabkin HA; Roche J
Neoplasia; 2009 Feb; 11(2):157-66. PubMed ID: 19177200
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect.
Kras P; Talkowski K; Grabarek BO; Skalska-Dziobek N; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(5):697-705. PubMed ID: 32648839
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of Bub1 mRNA expression in endometrial carcinoma Ishikawa cells by estrogen and paclitaxel].
Chen YH; Li XP; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):686-90. PubMed ID: 21092550
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
Joseph D; Ho SM; Syed V
Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
[TBL] [Abstract][Full Text] [Related]
16. Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines In Vitro Study.
Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer.
Talkowski K; Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(2):317-326. PubMed ID: 32564748
[TBL] [Abstract][Full Text] [Related]
18. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
[TBL] [Abstract][Full Text] [Related]
19. RORα suppresses breast tumor invasion by inducing SEMA3F expression.
Xiong G; Wang C; Evers BM; Zhou BP; Xu R
Cancer Res; 2012 Apr; 72(7):1728-39. PubMed ID: 22350413
[TBL] [Abstract][Full Text] [Related]
20. GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer.
Luvsandagva B; Nakamura K; Kitahara Y; Aoki H; Murata T; Ikeda S; Minegishi T
Gynecol Oncol; 2012 Jul; 126(1):132-9. PubMed ID: 22543280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
